Literature DB >> 20545037

Therapy: Solifenacin causes less dry mouth than oxybutynin in OAB.

Nick Warde.   

Abstract

Entities:  

Year:  2010        PMID： 20545037     DOI： 10.1038/nrurol.2010.73

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Tolerability of 5 mg solifenacin once daily versus 5 mg oxybutynin immediate release 3 times daily: results of the VECTOR trial.

Authors:  Sender Herschorn; Lynn Stothers; Kevin Carlson; Blair Egerdie; Jerzy B Gajewski; Peter Pommerville; Jane Schulz; Sidney Radomski; Harold Drutz; Jack Barkin; Fran Paradiso-Hardy
Journal:  J Urol       Date:  2010-03-29       Impact factor: 7.450
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.